Department of Radiation Oncology

CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer (2022) Lan B, Zeng S, Zhang S, Ren X, Xing Y, Kutschick I, Pfeffer S, et al. Journal article Influence of gender on radiosensitivity during radiochemotherapy of advanced rectal cancer (2022) Schuster B, Hecht M, Schmidt M, Haderlein M, Jost T, Büttner-Herold M, Weber K, et al. Journal article The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma (2022) Cathomas R, Lorch A, Bruins HM, Compérat EM, Cowan NC, Efstathiou JA, Fietkau R, et al. Journal article, Review article Extracranial temporal bone paragangliomas: Re-defining the role of otologic surgery within the scope of function-preserving multimodal concepts (2022) Mantsopoulos K, Thimsen V, Eisenhut F, Weissmann T, Putz F, Fietkau R, Iro H, et al. Journal article Influence of the Antigen Pattern Vector on the Dynamics in a Perceptron-Based Artificial Immune - Tumour- Ecosystem During and After Radiation Therapy (2022) Scheidegger S, Barba SM, Fellermann HM, Gaipl U Conference contribution Technical evaluation of the cone-beam computed tomography imaging performance of a novel, mobile, gantry-based X-ray system for brachytherapy (2021) Karius A, Karolczak M, Strnad V, Bert C Journal article Definitive chemoradiotherapy of locally advanced head and neck cancer in combination with immune checkpoint inhibition-new concepts required (2021) Hecht M, Fietkau R, Gaipl U Journal article, Editorial A Comparison of Single- and Multiparametric MRI Models for Differentiation of Recurrent Glioblastoma from Treatment-Related Change (2021) Eisenhut F, Engelhorn T, Arinrad S, Brandner S, Coras R, Putz F, Fietkau R, et al. Journal article Identification of an endogenous retroviral signature to predict PD-1 blockade response in advanced clear cell renal cell carcinoma: Integrated analysis of three clinical trials (2021) Zhou JG, Wang H, Ma H, Gaipl U Conference contribution An easily expandable multi-drug LC-MS assay for the simultaneous quantification of 57 oral antitumor drugs in human plasma (2021) Kehl N, Schlichtig K, Dürr P, Bellut L, Dörje F, Fietkau R, Pavel ME, et al. Journal article